Veradermics (MANE) operating margin

There is no operating margin history on record here for Veradermics (MANE). Figures as of 17 Nov 2026, 22:46 UTC, from Yahoo Finance.

Figures as of . Statements from Yahoo Finance. Figures, not advice.

Not enough data

A history of operating margin needs at least 3 fiscal years; none is on record here for Veradermics. Nothing is estimated to fill the gap.

Method

How it is calculated

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

How to read it

It shows how much of each unit of sales survives the cost of running the business — rising margins point to pricing power or scale, falling ones to pressure.

Operating margin at health care companies of similar size

Operating margin of Veradermics and comparable companies
CompanyOperating marginFiscal year
Scholar Rock Holding SRRK-404.8%2022
Teleflex TFX12.8%2025
Mirum Pharmaceuticals MIRM-4.2%2025
Grifols GRFS16.6%2025
Cogent Biosciences COGT-1044.3%2020

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on MANE

Veradermics, figure by figure

Veradermics (MANE) overview: price, valuation and scorecardAll health care companies by market value

Veradermics operating margin: questions and answers

How is Veradermics's operating margin calculated?

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Veradermics (MANE) operating margin”, data as of 17 November 2026. https://funkfolio.com/stock/MANE/operating-margin

Underlying data: Yahoo Finance.